Clinical Trial Update: A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating cetuximabβ in combination with envolimab and the mFOLFOX6 regimen for advanced colorectal cancer. The trial status is NOT_YET_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Envolimab (envolimab)

Snippet

Sponsor: Tao Zhang | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING